{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T19:32:42Z","timestamp":1783798362356,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.xphs.2018.04.019","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T13:11:09Z","timestamp":1524834669000},"page":"2070-2078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Urea Improves Stability of Inactivated Polio Vaccine Serotype 3 During Lyophilization and Storage in Dried Formulations"],"prefix":"10.1016","volume":"107","author":[{"given":"Wei","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Orgel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Francon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore W.","family":"Randolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2018.04.019_bib1","series-title":"Global Polio Eradication Intiative Strategic Plan 2004-2008","first-page":"1","year":"2003"},{"issue":"5","key":"10.1016\/j.xphs.2018.04.019_bib2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/rmv.401","article-title":"Polio eradication: the OPV paradox","volume":"13","author":"Dowdle","year":"2003","journal-title":"Rev Med Virol"},{"issue":"6","key":"10.1016\/j.xphs.2018.04.019_bib3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1590\/S0100-879X1997000600001","article-title":"Rare adverse events associated with oral poliovirus vaccine in Brazil","volume":"30","author":"Friedrich","year":"1997","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.xphs.2018.04.019_bib4","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","article-title":"Vaccine-derived polioviruses and the endgame strategy for global polio eradication","volume":"59","author":"Kew","year":"2005","journal-title":"Annu Rev Microbiol"},{"issue":"20","key":"10.1016\/j.xphs.2018.04.019_bib5","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1016\/j.vaccine.2009.02.071","article-title":"Vaccine-derived poliovirus (VDPV): impact on poliomyelitis eradication","volume":"27","author":"Minor","year":"2009","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.xphs.2018.04.019_bib6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1586\/erv.10.39","article-title":"Switching from OPV to IPV: are we behind the schedule in Latin America?","volume":"9","author":"Salas-Peraza","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.xphs.2018.04.019_bib7","series-title":"Pliomyelities Fact Sheet","year":"2011"},{"issue":"17","key":"10.1016\/j.xphs.2018.04.019_bib8","first-page":"5","article-title":"Outbreak of poliomyelitis in Tajikistan in 2010: risk for importation and impact on polio surveillance in Europe?","volume":"15","author":"Tajikis","year":"2010","journal-title":"Eurosurveillance"},{"issue":"5","key":"10.1016\/j.xphs.2018.04.019_bib9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1586\/erv.09.20","article-title":"Opportunities and challenges of developing thermostable vaccines","volume":"8","author":"Chen","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"10.1016\/j.xphs.2018.04.019_bib10","first-page":"261","article-title":"The durability of inactivated poliovirus vaccine: studies on the stability of potency in\u00a0vivo and in\u00a0vitro","volume":"10","author":"Moynihan","year":"1982","journal-title":"J\u00a0Biol Stand"},{"issue":"3","key":"10.1016\/j.xphs.2018.04.019_bib11","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/jmv.20202","article-title":"Isolation and characterisation of poliovirus mutants resistant to heating at 50\u00b0C for 30 min","volume":"74","author":"Shiomi","year":"2004","journal-title":"J\u00a0Med Virol"},{"issue":"10","key":"10.1016\/j.xphs.2018.04.019_bib12","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1007\/s11095-014-1359-6","article-title":"Development of thermostable lyophilized inactivated polio vaccine","volume":"31","author":"Kraan","year":"2014","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2018.04.019_bib13","unstructured":"Chouvenc P, Francon A. Symposium on Freeze-drying of Biologicals and Pharmaceuticals. Garmisch-partenkirchen. Germany, Sep 28, 2010 to Oct. 1, 2010."},{"issue":"2","key":"10.1016\/j.xphs.2018.04.019_bib14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3181\/00379727-86-21081","article-title":"Lyophilization of poliomyelitis virus. Heat inactivation of dry MEF1 virus","volume":"86","author":"Kraft","year":"1954","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.xphs.2018.04.019_bib15","series-title":"Viscosities of Sucrose Solutions at Various Temperatures: Tables\u00a0of Recalculated Values","author":"Swindells","year":"1958"},{"issue":"1","key":"10.1016\/j.xphs.2018.04.019_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF01250852","article-title":"Effect of lyophilization on picornaviruses","volume":"28","author":"Portocala","year":"1969","journal-title":"Arch Gesamte Virusforsch"},{"issue":"5","key":"10.1016\/j.xphs.2018.04.019_bib17","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1128\/am.22.5.850-853.1971","article-title":"Preservation of enteroviruses by freeze-drying","volume":"22","author":"Berge","year":"1971","journal-title":"Appl Microbiol"},{"issue":"2","key":"10.1016\/j.xphs.2018.04.019_bib18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.7883\/yoken.JJID.2003.70","article-title":"Heat stability of the lyophilized Sabin poliovaccine","volume":"56","author":"Shiomi","year":"2003","journal-title":"Jpn J Infect Dis"},{"issue":"1","key":"10.1016\/j.xphs.2018.04.019_bib19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/jps.23801","article-title":"Preformulation study of highly purified inactivated polio vaccine, serotype 3","volume":"103","author":"Qi","year":"2014","journal-title":"J\u00a0Pharm Sci"},{"issue":"18","key":"10.1016\/j.xphs.2018.04.019_bib20","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1016\/j.vaccine.2011.02.085","article-title":"Characterization and standardization of Sabin based inactivated polio vaccine: proposal for a new antigen unit for inactivated polio vaccines","volume":"29","author":"Westdijk","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.xphs.2018.04.019_bib21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.biologicals.2004.11.001","article-title":"Analysis of antigenic profiles of inactivated poliovirus vaccine and vaccine-derived polioviruses by block-ELISA method","volume":"33","author":"Rezapkin","year":"2005","journal-title":"Biologicals"},{"issue":"4","key":"10.1016\/j.xphs.2018.04.019_bib22","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1099\/0022-1317-74-4-685","article-title":"Antigenic structure of poliovirus in inactivated vaccines","volume":"74","author":"Ferguson","year":"1993","journal-title":"J\u00a0Gen Virol"},{"issue":"Pt 21","key":"10.1016\/j.xphs.2018.04.019_bib23","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1242\/jeb.01859","article-title":"Cryoprotection by urea in a terrestrially hibernating frog","volume":"208","author":"Costanzo","year":"2005","journal-title":"J\u00a0Exp Biol"},{"key":"10.1016\/j.xphs.2018.04.019_bib24","series-title":"Stabilizers for Live Vaccines","author":"Fanget","year":"2001"},{"key":"10.1016\/j.xphs.2018.04.019_bib25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/9780470110560.ch3","article-title":"Fluorescence techniques for studying protein-structure","volume":"35","author":"Eftink","year":"1991","journal-title":"Method Biochem Anal"},{"issue":"4720","key":"10.1016\/j.xphs.2018.04.019_bib26","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1126\/science.2994218","article-title":"3-Dimensional structure of poliovirus at 2.9 a resolution","volume":"229","author":"Hogle","year":"1985","journal-title":"Science"},{"issue":"Oct","key":"10.1016\/j.xphs.2018.04.019_bib27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1099\/0022-1317-37-1-127","article-title":"Structural subunits of poliovirus particles by electron-microscopy","volume":"37","author":"Boublik","year":"1977","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.xphs.2018.04.019_bib28","series-title":"Stabilizing Excipient for Inactivated Whole Virus Vaccine","author":"Francon","year":"2015"},{"key":"10.1016\/j.xphs.2018.04.019_bib29","series-title":"A\u00a0Stabilizer for the Preparation of a Dry Polio Injectable Vaccine Composition","author":"Francon","year":"2012"},{"issue":"9","key":"10.1016\/j.xphs.2018.04.019_bib30","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1002\/jps.21657","article-title":"Structural stability of hepatitis C virus envelope glycoprotein E1: effect of pH and dissociative detergents","volume":"98","author":"He","year":"2009","journal-title":"J\u00a0Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2018.04.019_bib31","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4161\/hv.6.2.10254","article-title":"Using spectroscopic and microscopic methods to probe the structural stability of human adenovirus type 4","volume":"6","author":"He","year":"2010","journal-title":"Hum Vaccin"},{"issue":"10","key":"10.1016\/j.xphs.2018.04.019_bib32","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1002\/jps.22618","article-title":"Multidimensional methods for the formulation of biopharmaceuticals and vaccines","volume":"100","author":"Maddux","year":"2011","journal-title":"J\u00a0Pharm Sci"},{"issue":"Supplement C","key":"10.1016\/j.xphs.2018.04.019_bib33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.addr.2014.10.023","article-title":"Formulation and stabilization of recombinant protein based virus-like particle vaccines","volume":"93","author":"Jain","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2018.04.019_bib34","series-title":"Vaccine Design: Methods and Protocols, Volume 2: Vaccines for Veterinary Diseases","first-page":"393","article-title":"Formulation studies during preclinical development of influenza hemagglutinin and virus-like particle vaccine candidates","author":"Wahome","year":"2016"},{"issue":"41","key":"10.1016\/j.xphs.2018.04.019_bib35","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1016\/j.vaccine.2017.03.101","article-title":"Development of a candidate stabilizing formulation for bulk storage of a double mutant heat labile toxin (dmLT) protein based adjuvant","volume":"35","author":"Toprani","year":"2017","journal-title":"Vaccine"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354918302223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354918302223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:24:53Z","timestamp":1758360293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354918302223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0022354918302223"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2018.04.019","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urea Improves Stability of Inactivated Polio Vaccine Serotype 3 During Lyophilization and Storage in Dried Formulations","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2018.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}